By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

enGene Holdings Inc. (ENGN)

NASDAQ Currency in USD
$6.06
-$0.23
-3.66%
Last Update: 11 Sept 2025, 20:00
$309.70M
Market Cap
30.64
P/E Ratio (TTM)
Forward Dividend Yield
$2.65 - $11.00
52 Week Range

ENGN Stock Price Chart

Explore enGene Holdings Inc. interactive price chart. Choose custom timeframes to analyze ENGN price movements and trends.

ENGN Company Profile

Discover essential business fundamentals and corporate details for enGene Holdings Inc. (ENGN) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

1 Feb 2022

Employees

56.00

CEO

Ronald H. W. Cooper

Description

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

ENGN Financial Timeline

Browse a chronological timeline of enGene Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 20 Dec 2025

Earnings released on 11 Sept 2025

EPS came in at -$0.57 falling short of the estimated -$0.51 by -12.12%.

Earnings released on 12 Jun 2025

EPS came in at -$0.51 falling short of the estimated -$0.50 by -2.00%.

Earnings released on 10 Mar 2025

EPS came in at -$0.48 falling short of the estimated -$0.37 by -29.73%.

Earnings released on 20 Dec 2024

EPS came in at -$0.34 surpassing the estimated -$0.48 by +28.69%.

Earnings released on 10 Sept 2024

EPS came in at -$0.32 surpassing the estimated -$0.37 by +13.51%.

Earnings released on 14 Jun 2024

EPS came in at -$0.38 falling short of the estimated -$0.26 by -46.15%.

Earnings released on 11 Mar 2024

EPS came in at -$0.46 falling short of the estimated -$0.42 by -11.26%.

Earnings released on 31 Oct 2023

EPS came in at -$2.64 .

Earnings released on 31 Jul 2023

EPS came in at -$0.30 .

Earnings released on 30 Apr 2023

EPS came in at -$0.33 .

Earnings released on 31 Jan 2023

EPS came in at -$0.47 .

Earnings released on 31 Oct 2022

EPS came in at -$0.53 .

Earnings released on 31 Jul 2022

EPS came in at -$0.43 .

Earnings released on 30 Apr 2022

EPS came in at -$0.34 .

Earnings released on 30 Dec 2021

EPS came in at -$0.01 .

ENGN Stock Performance

Access detailed ENGN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run